Teva has launched a generic version of Prometrium capsules for the treatment of secondary amenorrhea, a cessation in menstrual periods for more than six months. The illness is due to a decrease in the hormone progesterone. The drug is also given to menopausal women together with estrogen-containing medications.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israel's Top Hospital Unveils Program To Promote HealthTech Startups
September 12, 2024
Battery Startup Announces Superfast Charging For Electric Vehicles
September 12, 2024
Automated Marketing Firm Unveils New Image Editing Suite
September 11, 2024
Israeli Renewable Energy Firm Launches First US Solar Power Project
September 11, 2024
Facebook comments